IGF1R and neoplasm: We recently showed that in a group of 19 patients (paired chemo-naive and NACT-treated), overexpression of insulin-like growth factor 1 receptor (IGF1R) in tumour samples (primary and metastatic) correlated with prolonged OS and disease-free survival (DFS) as compared to patients harbouring tumours with low IGF1R expression [55].